MedPath

Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients

Recruiting
Conditions
Testicular Cancer
Interventions
Other: Observation of testicular cancer patients
Registration Number
NCT06389409
Lead Sponsor
IRCCS San Raffaele
Brief Summary

The research aims to collect data in order to report the main problems related to the testicular cancer; To reach this aim, this study proposes to create a database of the testicular cancer condition.

From this perspective, the aim of this project is the improving of scientific knowledge of the disease and develop appropriate and effective procedures for the diagnosis and treatment of the patient.

Detailed Description

Testicular cancer constitutes 1% to 1.5% of male tumors, 5% of urological tumors. In the Western society to which we belong, the incidence is between 3 and 6 new cases per 100,000 inhabitants per year. In particular, this incidence has recorded continuous growth over the last thirty years. Different histologies of this disease are known, with a clear prevalence of germ cell tumors (90-95%).

From these general epidemiological coordinates it can be deduced that this pathology could affects a young segment of the population; It must be underlined that a pathology is peculiar due to the impact it has on the affected individual, who must be treated not only from an oncological point of view but also with regards to the sexual, reproductive and psychological-relational aspects. Such complexity requires a systematic and detailed approach to examine all aspects.

The creation of this database let to have a follow up above all an extension over time that is not present in the literature, especially towards the functional aspects of this condition.

The database will represent a resource for future research.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
3000
Inclusion Criteria
  • subjects suffering from suspected neoplastic testicular pathology candidates for testicle removal surgery
  • patients suffering from neoplastic testicular pathology requiring removal of the retroperitoneal lymph nodes
  • subjects > 18 years old
  • subjects with at least elementary education
  • signature of informed consent
Exclusion Criteria
  • subjects < 18 years
  • presence of mental or physical disability that may prevent the patient from satisfying the requirements of the protocol

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patient with testicular cancerObservation of testicular cancer patients* subjects suffering from suspected neoplastic testicular pathology candidates for testicle removal surgery * patients suffering from neoplastic testicular pathology requiring removal of the retroperitoneal lymph nodes
Primary Outcome Measures
NameTimeMethod
Clinical dataBaseline

Collection of clinical data

Testicular objective examinationBaseline

Number and size (via Prader orchidometer) of the testicles

Adjuvant therapyBaseline

Which type of adjuvant therapy carried out (chemotherapy - radiotherapy - retroperitoneal lymphadenectomy)

lactate dehydrogenaseFollow up after 6 months from baseline

Oncological follow-up through enzymatic value

Testicular objective examination - nodulesBaseline

Evaluation presence of nodules

Testicular objective examination - hydroceleBaseline

Evaluation presence of hydrocele

α-feto proteinFollow up after 6 months from baseline

Oncological follow-up through enzymatic value

Testicular objective examination - cystsBaseline

Evaluation presence of cysts

Testicular objective examination - varicoceleBaseline

Evaluation presence of varicocele

β human Chorionic GonadotropinFollow up after 6 months from baseline

Oncological follow-up through hormonal value

carcinoembryonic antigenFollow up after 6 months from baseline

Oncological follow-up through hormonal value

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IRCCS Ospedale San Raffaele

🇮🇹

Milan, Lombardy, Italy

© Copyright 2025. All Rights Reserved by MedPath